Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Nuveen Growth Opportunities ETF
NUGO
|
+$3.29B |
| 2 |
Palo Alto Networks
PANW
|
+$524M |
| 3 |
Broadcom
AVGO
|
+$416M |
| 4 |
Qualcomm
QCOM
|
+$412M |
| 5 |
Tesla
TSLA
|
+$391M |
Top Sells
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$1.21B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$662M |
| 3 |
Apple
AAPL
|
+$607M |
| 4 |
Amazon
AMZN
|
+$530M |
| 5 |
Meta Platforms (Facebook)
META
|
+$523M |
Sector Composition
| 1 | Technology | 26.37% |
| 2 | Consumer Discretionary | 12.42% |
| 3 | Healthcare | 12.26% |
| 4 | Financials | 12.19% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2976
YPF
YPF
$10.6B
| $682K | ﹤0.01% |
178,500
-280,166
| -61% | -$1.07M |
|
2977
EverCommerce
EVCM
$2.12B
| $678K | ﹤0.01% |
42,156
-14,301
| -25% | -$230K |
|
|
INST
2978
DELISTED
Instructure Holdings, Inc.
INST
| $678K | ﹤0.01% |
30,125
+2,472
| +9% | +$55.6K |
|
2979
Teekay
TK
$734M
| $677K | ﹤0.01% |
221,352
-35,035
| -14% | -$107K |
|
|
OYST
2980
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $672K | ﹤0.01% |
52,905
-6,079
| -10% | -$77.2K |
|
2981
Ryanair
RYAAY
$31.7B
| $671K | ﹤0.01% |
16,395
| – | – |
|
2982
FS Bancorp
FSBW
$318M
| $670K | ﹤0.01% |
20,154
-2,264
| -10% | -$75.3K |
|
|
FTSI
2983
DELISTED
FTS International, Inc. Common Stock
FTSI
| $670K | ﹤0.01% |
25,592
-3,535
| -12% | -$92.5K |
|
2984
NI Holdings
NODK
$277M
| $668K | ﹤0.01% |
35,482
-1,761
| -5% | -$33.2K |
|
2985
Q32 Bio
QTTB
$21.3M
| $668K | ﹤0.01% |
10,193
-619
| -6% | -$40.6K |
|
2986
Vor Biopharma
VOR
$255M
| $666K | ﹤0.01% |
54,248
-4,275
| -7% | -$52.5K |
|
2987
Tonix Pharmaceuticals
TNXP
$226M
| $665K | ﹤0.01% |
3
| – | – |
|
2988
89bio
ETNB
$1.27B
| $664K | ﹤0.01% |
56,140
-4,152
| -7% | -$49.1K |
|
2989
Ceco Environmental
CECO
$1.59B
| $662K | ﹤0.01% |
111,030
-9,673
| -8% | -$57.7K |
|
2990
Lyell Immunopharma
LYEL
$250M
| $662K | ﹤0.01% |
3,644
+1,354
| +59% | +$246K |
|
2991
Village Super Market
VLGEA
$554M
| $658K | ﹤0.01% |
30,399
-2,165
| -7% | -$46.9K |
|
2992
Spyre Therapeutics
SYRE
$1B
| $653K | ﹤0.01% |
6,753
-433
| -6% | -$41.9K |
|
|
ITI
2993
DELISTED
Iteris, Inc.
ITI
| $653K | ﹤0.01% |
174,148
-12,602
| -7% | -$47.3K |
|
2994
Donegal Group Class A
DGICA
$704M
| $643K | ﹤0.01% |
45,904
-7,575
| -14% | -$106K |
|
2995
National CineMedia
NCMI
$435M
| $643K | ﹤0.01% |
25,683
-1,862
| -7% | -$46.6K |
|
|
PSTX
2996
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $643K | ﹤0.01% |
97,594
-10,090
| -9% | -$66.5K |
|
2997
uniQure
QURE
$960M
| $640K | ﹤0.01% |
30,880
-4,295
| -12% | -$89K |
|
2998
Immunic
IMUX
$84.6M
| $638K | ﹤0.01% |
75,378
-5,608
| -7% | -$47.5K |
|
2999
Kura Sushi USA
KRUS
$970M
| $636K | ﹤0.01% |
9,846
| – | – |
|
3000
Harvard Bioscience
HBIO
$20.2M
| $631K | ﹤0.01% |
91,011
-27,445
| -23% | -$190K |
|